DUBLIN, Ireland, Jan. 28 /PRNewswire-FirstCall/ -- Elan Corporation, plc
(NYSE: ELN) ("Elan") announced today that it will report fourth-quarter and
full-year 2001 financial results on Monday, February 4, 2002, before the
financial markets open. The announcement will be followed by a conference
call at 8:30 a.m. Eastern Time with the investment community, and feature
members of Elan's Senior Management Team.
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media, investors and
the general public. The conference call is expected to last approximately one
hour.
This event can be accessed by to Elan's website, http://www.elan.com, and
clicking on the Investor Relations section, then on the event icon. The event
will be archived and available for replay for 48 hours after the event.
Elan Corporation, plc. is a leading worldwide, fully integrated
biopharmaceutical company headquartered in Ireland, with its principal
research, development, manufacturing and marketing facilities located in
Ireland, the United States and the United Kingdom. Elan is focused on the
marketing of therapeutic products and services in neurology, pain management,
oncology, infectious disease and dermatology and on the development and
commercialization of products using its extensive range of proprietary drug
delivery technologies. Elan shares trade on the New York, London and Dublin
Stock Exchanges.
SOURCE Elan Corporation, plc
back to top
Related links: http://www.elan.com
Company News On-Call: http://www.prnewswire.com/comp/231593.html
CONTACT: Investors - U.S., Jack Howarth, +1-212-407-5740, or +1-800-252-3526, or Investors - Europe, Emer Reynolds, +353-1-709-4000, or +00800-28352600, both for Elan Corporation, plc
|